MOTS-c, acting mostly via skeletal muscle, targets the methionine-folate cycle and connected de novo purine biosynthesis, increases the AICAR (5-aminoimidazole-4-carboxamide ribonucleotide) levels and activates AMPK, thus ameliorating IR and diet-induced obesity [3]. The gene discussed is MT-RNR1; the disease is obesity disorder.